Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Christian Wienberg - Danish Economy Ministry Raises GDP Forecast Due to Pharma Sales
Danish Economy Ministry Raises GDP Forecast Due to Pharma Sales
Bloomberg

Denmark's gross domestic product will expand at a faster pace than previously expected due to strong sales from the country's pharmaceutical industry, which is dominated by Novo Nordisk A/S, the economy ministry said. GDP will rise 2.7% this year…

rediff.com - Anjali Singh - Sun Pharma US generics biz remains under pressure
Sun Pharma US generics biz remains under pressure
Rediff.com

Sun Pharmaceutical Industries reported robust consolidated financial results for Q4 FY26, showcasing significant profit and revenue growth, even as its crucial US generics business continues to face challenges, prompting a strategic pivot towards…

thehindubusinessline.com - Surat-based Anupam Rasayan India to acquire upto 74.2 per cent in Bliss GVS Pharma
Surat-based Anupam Rasayan India to acquire upto 74.2 per cent in Bliss GVS Pharma
BusinessLine

Surat-based Anupam Rasayan India Ltd said it was acquiring upto 74.2 per cent in Bliss GVS Pharma Limited, a Mumbai-based formulations company. A provider of custom synthesis and specialty chemicals Anupam Rasayan said in a statement it was picking…

marketbeat.com - Cumberland Partners Ltd Buys Shares of 35,000 Royalty Pharma PLC $RPRX
Cumberland Partners Ltd Buys Shares of 35,000 Royalty Pharma PLC $RPRX
MarketBeat

Cumberland Partners Ltd bought a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 35,000 shares…

businessinsider.com - Dylan Brzezinski - How the opioid black market actually works, according to a former pill mill owner
How the opioid black market actually works, according to a former pill mill owner
Business Insider

Jason Votrobek was convicted in 2014 on drug trafficking and money laundering charges and later sentenced to 15 years in federal prison. Votrobek talks to Business Insider about his early days smuggling cocaine and his role in the prescription…

fool.com - Jonathan Ponciano - What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge
What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge
The Motley Fool

Superstring Capital Management cut its stake in UroGen Pharma Ltd. (URGN 3.31%), selling 330,983 shares in the first quarter in an estimated $6.64 million trade based on average quarterly pricing, according to a May 14, 2026, SEC filing. According…

theguardian.com - Julia Kollewe - Final frontier for meds? UK startup sends drug-making into space
Final frontier for meds? UK startup sends drug-making into space
The Guardian

Onboard a SpaceX flight last week was a remarkable piece of cargo – a hi-tech box destined for the International Space Station to grow ultra-pure protein crystals, with the aim of producing self-injected cancer drugs. A British startup…

thehindu.com - The Hindu Bureau - BRS desperate to damage Hyderabad's image: Sridhar Babu
BRS desperate to damage Hyderabad's image: Sridhar Babu
The Hindu

Industries and IT Minister Sridhar Babu said the Bharat Rashtra Samithi (BRS) leader T Harish Rao's statement that ‘Future City' would be cancelled if Bharat Rashtra Samithi (BRS) came to power, was intended to discourage investments and…

fool.com - Jeff Siegel - Is Viking Therapeutics a Top Takeover Target?
Is Viking Therapeutics a Top Takeover Target?
The Motley Fool

Viking Therapeutics (VKTX +0.68%) increasingly looks like an acquisition candidate in biotech. But why? It's because large pharmaceutical companies are desperate to secure obesity drug exposure, and Viking controls one of the more advanced…

nypost.com - Sonya Gugliara - Exclusive | Ghoulish Mangionista groupie is healthcare exec's relative
Exclusive | Ghoulish Mangionista groupie is healthcare exec's relative
New York Post

One of the ghoulish Luigi Mangione fangirl “journalists” is herself the relative of a health care insurance executive, The Post has learned. Lena Weissbrot, a member of the twisted trio hopelessly devoted to the accused assassin of…

marketbeat.com - Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of 'Buy' from Brokerages
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of 'Buy' from Brokerages
MarketBeat

Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) have received an average recommendation of 'Buy' from the fifteen brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the…

marketbeat.com - Rathbones Group PLC Purchases 32,270 Shares of Novo Nordisk A/S $NVO
Rathbones Group PLC Purchases 32,270 Shares of Novo Nordisk A/S $NVO
MarketBeat

Rathbones Group PLC increased its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 79.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor…

newsbytesapp.com - Dwaipayan Roy - FIIs pull out ₹30,374cr from Indian equities in May
FIIs pull out ₹30,374cr from Indian equities in May
NewsBytes

What's the story Foreign institutional investors (FIIs) have sold Indian equities worth ₹2.22 lakh crore in 2026, continuing their net selling streak for the third consecutive month. So far this month, they have sold shares worth…

marketbeat.com - Novo Nordisk A/S $NVO Shares Purchased by Markel Group Inc.
Novo Nordisk A/S $NVO Shares Purchased by Markel Group Inc.
MarketBeat

Markel Group Inc. raised its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 21.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor…

thehindubusinessline.com - Mutual Funds returns
Mutual Funds returns
BusinessLine

EQUITY - LARGE & MID CAP FUNDS Bandhan Large & Mid Cap Fund HYBRID - AGGRESSIVE HYBRID FUNDS BOI AXA Mid & Small Cap Eq&Debt HYBRID - BALANCED ADVANTAGE FUNDS Baroda BNP Paribas Balanced Advantage EQUITY - LARGE CAP FUNDS Canara Robeco Large Cap…

Receive a Daily briefing on Pharma Industry News

Get Started